GFAP and stroke disorder: The expression of vessel-associated C3d (a marker of the toxic A1 phenotype, Figure 7B (a-c) red) and S100A10 (a marker of the protective A2 phenotype, Figure 7B (d-f) red) were co-labeled with GFAP in the peri-infarct brain regions 22 days after PT stroke.